Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03313549
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
CAU | (2S)-1-(9H-Carbazol-4-yloxy)-3- (isopropylamino)propan-2-ol | A | 2RH1 | 0.71 | |
K2C | 6,7,12,13-tetrahydro-5H-indolo[2,3- a]pyrrolo[3,4-c]carbazol-5-one | A | 2R0P | 0.72 | |
UCN | 7-HYDROXYSTAUROSPORINE | A | 1OKZ | 0.75 | |
UCN | 7-HYDROXYSTAUROSPORINE | A,C | 1PKD | 0.75 | |
UCN | 7-HYDROXYSTAUROSPORINE | A | 1NVQ | 0.75 | |
SA3 | 2,10-DIHYDROXY-12-(BETA-D-GLUCOPYRANOSYL)- 6,7,12,13-TETRAHYDROINDOLO[2,3- A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE | A,C,D | 1SEU | 0.75 | |
TCR | CYCLOMETHYLTRYPTOPHAN | A | 3AIG | 0.72 | |
KSA | K-252A | A | 1R0P | 0.75 | |
KSA | K-252A | A | 3EQF | 0.75 | |
CRZ | 4-(9H-CARBAZOL-9-YL)BUTANOIC ACID | A | 1TOW | 0.73 | |
PDS | 3-{1-[3-(DIMETHYLAMINO)PROPYL]- 2-METHYL-1H-INDOL-3-YL}-4-(2-METHYL- 1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE | A,B | 2I0E | 0.72 | |
4F3 | [2-(1-AMINO-2-HYDROXY-PROPYL)-4- (4-FLUORO-1H-INDOL-3-YLMETHYL)- 5-HYDROXY-IMIDAZOL-1-YL]-ACETIC ACID | A | 1RM9 | 0.7 | |
NYC | [(4E)-2-[(1R,2S)-1-AMINO-2-HYDROXYPROPYL]- 4-(1H-INDOL-3-YLMETHYLENE)-5-OXO- 4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID | A | 2Q57 | 0.71 | |
NYC | [(4E)-2-[(1R,2S)-1-AMINO-2-HYDROXYPROPYL]- 4-(1H-INDOL-3-YLMETHYLENE)-5-OXO- 4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID | A | 1OXE | 0.71 | |
NYC | [(4E)-2-[(1R,2S)-1-AMINO-2-HYDROXYPROPYL]- 4-(1H-INDOL-3-YLMETHYLENE)-5-OXO- 4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID | A | 1OXD | 0.71 | |
115 | 7-[3-(4-FLUORO-PHENYL)-1-ISOPROPYL- 1H-INDOL-2-YL]-3,5-DIHYDROXY-HEPTANOIC ACID | A,B,C,D | 1HWI | 0.71 | |
1ST | (5S,6R,7R,9R)-12-HYDROXY-6-METHOXY- 5-METHYL-7-(METHYLAMINO)-6,7,8,9- TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15- TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4- JKL]CYCLOPENTA[E]-AS-INDACEN-14- ONE | 1 | 2HY8 | 0.72 | |
710 | (5-{3-[5-(PIPERIDIN-1-YLMETHYL)- 1H-INDOL-2-YL]-1H-INDAZOL-6-YL}- 2H-1,2,3-TRIAZOL-4-YL)METHANOL | A | 2HOG | 0.71 | |
UCM | REL-(9R,12S)-9,10,11,12-TETRAHYDRO- 9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'- KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE- 1,3(2H)-DIONE | A | 1NVS | 0.72 | |
WSA | 5'-O-[(L-TRYPTOPHYLAMINO)SULFONYL]ADENOSINE | A,B,C,D | 2YY5 | 0.71 | |
RDF | N-ALPHA-L-RHAMNOPYRANOSYLOXY(HYDROXYPHOSPHINYL)- L-LEUCYL-L-TRYPTOPHAN | A | 1DMT | 0.71 | |
RDF | N-ALPHA-L-RHAMNOPYRANOSYLOXY(HYDROXYPHOSPHINYL)- L-LEUCYL-L-TRYPTOPHAN | A | 3DWB | 0.71 | |
RDF | N-ALPHA-L-RHAMNOPYRANOSYLOXY(HYDROXYPHOSPHINYL)- L-LEUCYL-L-TRYPTOPHAN | A | 3DBK | 0.71 | |
P83 | 1-(9-ethyl-9H-carbazol-3-yl)-N- methylmethanamine | A,B | 2VUK | 0.72 | |
LY4 | (9R)-9-[(DIMETHYLAMINO)METHYL]- 6,7,10,11-TETRAHYDRO-9H,18H-5,21:12,17- DIMETHENODIBENZO[E,K]PYRROLO[3,4- H][1,4,13]OXADIAZACYCLOHEXADECINE- 18,20-DIONE | B | 2J2I | 0.73 | |
LY4 | (9R)-9-[(DIMETHYLAMINO)METHYL]- 6,7,10,11-TETRAHYDRO-9H,18H-5,21:12,17- DIMETHENODIBENZO[E,K]PYRROLO[3,4- H][1,4,13]OXADIAZACYCLOHEXADECINE- 18,20-DIONE | A | 1UU3 | 0.73 | |
VAW | (2S,3R,4S)-methyl 4-(2-(2-(1H-indol- 3-yl)ethylamino)ethyl)-2-((2S,3R,4S,5S,6R)- 3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro- 2H-pyran-2-yloxy)-3-vinyl-3,4-dihydro- 2H-pyran-5-carboxylate | A,B | 2VAQ | 0.71 | |
4ST | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | A | 2J0J | 0.8 | |
4ST | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | B | 2J0M | 0.8 | |
4ST | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | A,B | 2J0K | 0.8 | |
4ST | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | A | 1YVJ | 0.8 | |
4ST | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | A,B,C | 2HZ4 | 0.8 | |
IPF | N-ACETYLTRYPTOPHYL-N~1~-{3-[1-(N- ACETYLTRYPTOPHYLVALYL)PYRROLIDIN- 2-YL]-1-BENZYL-2,3-DIHYDROXYPROPYL}VALINAMIDE | A,B | 2A1E | 0.74 | |
IMK | 2-(BETA-D-GLUCOPYRANOSYL)-5-METHYL- 1-BENZIMIDAZOLE | A | 1XKX | 0.7 | |
KAW | N-{(5S)-4,4-dihydroxy-6-phenyl- 5-[(phenylcarbonyl)amino]hexanoyl}- L-tryptophan | A | 3BKL | 0.7 | |
XDR | hexyl (5S,6R,8R)-6-hydroxy-5-methyl- 13-oxo-5,6,7,8-tetrahydro-13H-5,8- epoxy-4b,8a,14-triazadibenzo[b,h]cycloocta[1,2,3,4- jkl]cyclopenta[e]-as-indacene-6- carboxylate | A,B | 3F69 | 0.73 | |
3LP | 1-(CYCLOHEXYLAMINO)-3-(6-METHYL- 3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN- 2-OL | A,B,C,D,E,F | 2P6G | 0.74 | |
CMF | 3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL- 2-OXOETHYL)-2-PHENYL-1H-INDOLE- 6-CARBOXYLIC ACID | A | 2BRK | 0.72 | |
2IG | 6-ETHYL-5-[9-(3-METHOXYPROPYL)- 9H-CARBAZOL-2-YL]PYRIMIDINE-2,4- DIAMINE | A,B | 2G1O | 0.7 | |
LI3 | 3-FLUORO-N-1H-INDOL-5-YL-5-MORPHOLIN- 4-YLBENZAMIDE | A | 1WBV | 0.7 | |
FRN | A | 2CV3 | 0.73 | ||
S55 | METHYL (2S,3R,4S)-3-ETHYL-2-(BETA- D-GLUCOPYRANOSYLOXY)-4-[(1S)-2,3,4,9- TETRAHYDRO-1H-BETA-CARBOLIN-1-YLMETHYL]- 3,4-DIHYDRO-2H-PYRAN-5-CARBOXYLATE | A,B | 2JF6 | 0.72 | |
S55 | METHYL (2S,3R,4S)-3-ETHYL-2-(BETA- D-GLUCOPYRANOSYLOXY)-4-[(1S)-2,3,4,9- TETRAHYDRO-1H-BETA-CARBOLIN-1-YLMETHYL]- 3,4-DIHYDRO-2H-PYRAN-5-CARBOXYLATE | A,B | 2V91 | 0.72 | |
TYM | TRYPTOPHANYL-5'AMP | A,B | 2QUJ | 0.71 | |
TYM | TRYPTOPHANYL-5'AMP | A | 1I6K | 0.71 | |
TYM | TRYPTOPHANYL-5'AMP | A,B | 1R6U | 0.71 | |
TYM | TRYPTOPHANYL-5'AMP | A | 1I6M | 0.71 | |
TYM | TRYPTOPHANYL-5'AMP | A,B | 1R6T | 0.71 | |
TYM | TRYPTOPHANYL-5'AMP | A | 1I6L | 0.71 | |
STU | STAUROSPORINE | A,B | 3CBL | 0.8 | |
STU | STAUROSPORINE | A | 1QPJ | 0.8 | |
STU | STAUROSPORINE | A,B | 3CD3 | 0.8 | |
STU | STAUROSPORINE | A | 2ITU | 0.8 | |
STU | STAUROSPORINE | A,B | 2BUJ | 0.8 | |
STU | STAUROSPORINE | A,B | 2CLQ | 0.8 | |
STU | STAUROSPORINE | A | 1XBC | 0.8 | |
STU | STAUROSPORINE | A | 2ITW | 0.8 | |
STU | STAUROSPORINE | A | 1E8Z | 0.8 | |
STU | STAUROSPORINE | A | 1YHS | 0.8 | |
STU | STAUROSPORINE | A,B | 3D7T | 0.8 | |
STU | STAUROSPORINE | A | 1QPD | 0.8 | |
STU | STAUROSPORINE | A | 2Z7R | 0.8 | |
STU | STAUROSPORINE | A,B,C,D | 2NRY | 0.8 | |
STU | STAUROSPORINE | A | 1U59 | 0.8 | |
STU | STAUROSPORINE | A | 1NVR | 0.8 | |
STU | STAUROSPORINE | A,B,C,D | 2OIC | 0.8 | |
STU | STAUROSPORINE | A | 1AQ1 | 0.8 | |
STU | STAUROSPORINE | A | 1BYG | 0.8 | |
STU | STAUROSPORINE | A,B | 1SM2 | 0.8 | |
STU | STAUROSPORINE | X | 2DQ7 | 0.8 | |
STU | STAUROSPORINE | A | 3CKX | 0.8 | |
STU | STAUROSPORINE | A,B | 1Q3D | 0.8 | |
STU | STAUROSPORINE | E | 1STC | 0.8 | |
STU | STAUROSPORINE | A | 1OKY | 0.8 | |
STU | STAUROSPORINE | A | 1WVY | 0.8 | |
STU | STAUROSPORINE | A | 2HW7 | 0.8 | |
STU | STAUROSPORINE | A,B | 1SNU | 0.8 | |
STU | STAUROSPORINE | A | 2ITQ | 0.8 | |
STU | STAUROSPORINE | A,B,C,D | 1NXK | 0.8 | |
STU | STAUROSPORINE | A | 3BKB | 0.8 | |
STU | STAUROSPORINE | A | 1XJD | 0.8 | |
STU | STAUROSPORINE | A | 3FME | 0.8 | |
STU | STAUROSPORINE | A,B | 2GCD | 0.8 | |
STU | STAUROSPORINE | A,B,C | 2PZY | 0.8 | |
CP4 | BIS[5-CHLORO-1H-INDOL-2-YL-CARBONYL- AMINOETHYL]-ETHYLENE GLYCOL | A,B | 1EM6 | 0.7 | |
LI2 | 3-FLUORO-5-MORPHOLIN-4-YL-N-[3- (2-PYRIDIN-4-YLETHYL)-1H-INDOL- 5-YL]BENZAMIDE | A | 1WBS | 0.7 | |
YPA | (S)-3-(4-(2-CARBAZOL-9-YL-ETHOXY)- PHENYL)-2-ETHOXY-PROPIONIC ACID | A | 1KNU | 0.7 | |
SNX | 2-[(2-methoxyethyl)amino]-4-(4- oxo-1,2,3,4-tetrahydro-9H-carbazol- 9-yl)benzamide | A | 3D0B | 0.7 | |
4MF | 1-(2-DEOXY-5-O-PHOSPHONO-BETA-D- ERYTHRO-PENTOFURANOSYL)-4-METHYL- 1H-INDOLE | C | 2OXM | 0.72 | |
4MF | 1-(2-DEOXY-5-O-PHOSPHONO-BETA-D- ERYTHRO-PENTOFURANOSYL)-4-METHYL- 1H-INDOLE | B,C | 2OYT | 0.72 |